Options Trading News

December 12, 2012  Wed 7:31 AM CT


Glaucoma Drug Going to Market

Sucampo Pharmaceuticals said that the Food and Drug Administration approved its Rescula drug for patients suffering open-angle glaucoma. The product will be marketed in the first quarter of next year. SCMP is up 14 percent before the bell on my tradeMONSTER platform.

Costco Earnings, Revenue Beat

Costco reported first-quarter earnings of $0.95 a share, beating the $0.93 consensus estimate. Revenue of $23.72 billion also beat the $23.67 billion expected by analysts. COST is up 1 percent in early trading.

Clearwire Up on Buyout Chatter

Clearwire popped yesterday on reports that Sprint Nextel would buy out minority investors Intel and Comcast. CLWR, which offers wireless broadband services, is active again this morning and is up another 3 percent in the premarket.

Share this article with your friends


Premium Services

Education & Strategy

The art of trading

As I stated in last week's article, a break out or a break down needs to have a couple things happen before it is considered a confirmed break out or break down. The only problem is that in today's market where things move much more quicker than they did just a few years ago, two days could wind up being the majority of the expected movement, if not the whole movement.

View more education articles »